Lenvatinib plus pembrolizumab for patients with previously treated advanced ovarian cancer: Results from the phase 2 multicohort LEAP-005 study.
González-Martín A, Chung HC, Saada-Bouzid E, Yanez E, Senellart H, Cassier PA, Basu B, Corr BR, Girda E, Dutcus C, Okpara CE, Ghori R, Jin F, Groisberg R, Lwin Z.
González-Martín A, et al. Among authors: jin f.
Gynecol Oncol. 2024 May 7;186:182-190. doi: 10.1016/j.ygyno.2024.04.011. Online ahead of print.
Gynecol Oncol. 2024.
PMID: 38718741